The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
Making diagrams saves time, reduces ambiguity, and leaves a memorable impression on examiners. Check tips shared by the ...
Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...
Sidewinder achieves highly accurate assembly of long DNA sequences from scratch, offering a new leap forward for programmable biology ...
Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...
The "Proteinase K - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The Proteinase K market is projected to ...
The Central Board of Secondary Education schedules Class 10 and 12 exams from February 17, 2026, highlighting key questions and topics.
Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic biology sectors, driven by advancements in molecular cloning, drug discovery, ...
New York startup Helaina, which ferments microbes to create recombinant breast milk proteins, is ushering in a new dawn for ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...
Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results